| BANK OF AMERICA CORPORATION56-0906609 |
|
0 |
2084019 |
0 |
2096081 |
2096081 |
5.8 % |
13/02/2024 |
| Adage Capital Partners, L.P. |
Delaware |
0 |
3034255 |
0 |
0 |
3034255 |
8.38 % |
21/12/2023 |
| Adage Capital Management, L.P. |
Delaware |
0 |
3034255 |
0 |
0 |
3034255 |
8.38 % |
21/12/2023 |
| Adage Capital Partners GP, L.L.C. |
Delaware |
0 |
3034255 |
0 |
0 |
3034255 |
8.38 % |
21/12/2023 |
| Phillip Gross |
United States |
0 |
3034255 |
0 |
0 |
3034255 |
8.38 % |
21/12/2023 |
| Robert Atchinson |
United States |
0 |
3034255 |
0 |
0 |
3034255 |
8.38 % |
21/12/2023 |
| LP |
State of Delaware |
0 |
1835387 |
0 |
0 |
1835387 |
5.97 % |
10/02/2023 |
| David Rosen |
United States of America |
0 |
1835387 |
0 |
0 |
1835387 |
5.97 % |
10/02/2023 |
| RA Capital Management, L.P. |
Delaware |
0 |
4304447 |
0 |
10 |
4304447 |
14.57 % |
12/08/2022 |
| Peter Kolchinsky |
United States |
0 |
4304447 |
0 |
10 |
4304447 |
14.57 % |
12/08/2022 |
| RA Capital Healthcare Fund, L.P. |
United States |
0 |
3860662 |
0 |
10 |
3860662 |
13.07 % |
12/08/2022 |
| Rajeev Shah |
United States |
0 |
4304447 |
0 |
10 |
4304447 |
14.57 % |
12/08/2022 |
| James E. Flynn |
Delaware |
0 |
958125 |
0 |
0 |
958125 |
3.47 % |
11/02/2022 |
| Deerfield Partners, L.P. |
Delaware |
0 |
958125 |
0 |
0 |
958125 |
3.47 % |
11/02/2022 |
| Company, L.P. |
Delaware |
0 |
958125 |
0 |
0 |
958125 |
3.47 % |
11/02/2022 |
| Deerfield Mgmt, L.P. |
Delaware |
0 |
958125 |
0 |
0 |
958125 |
3.47 % |
11/02/2022 |
| MPM Oncology Impact Management LP |
|
2414787 |
0 |
2414787 |
0 |
2414787 |
8.8 % |
14/05/2021 |
| MPM BioVentures 2014, L.P. |
|
2919552 |
0 |
2919552 |
0 |
2919552 |
10.6 % |
14/05/2021 |
| MPM BioVentures 2014 (B), L.P. |
|
194729 |
0 |
194729 |
0 |
194729 |
0.7 % |
14/05/2021 |
| MPM Asset Management Investors BV2014 LLC |
|
100490 |
0 |
100490 |
0 |
100490 |
0.4 % |
14/05/2021 |
| MPM Asset Management LLC |
|
461408 |
0 |
461408 |
0 |
461408 |
1.7 % |
14/05/2021 |
| MPM Oncology Innovations Fund, L.P. |
|
640121 |
0 |
640121 |
0 |
640121 |
2.3 % |
14/05/2021 |
| UBS Oncology Impact Fund, L.P. |
|
2414787 |
0 |
2414787 |
0 |
2414787 |
8.8 % |
14/05/2021 |
| MPM BioVentures 2014 GP LLC |
|
0 |
3114281 |
0 |
3114281 |
3114281 |
11.3 % |
14/05/2021 |
| MPM BioVentures 2014 LLC |
|
0 |
3214771 |
0 |
3214771 |
3214771 |
11.7 % |
14/05/2021 |
| MPM Oncology Innovations Fund GP LLC |
|
0 |
640121 |
0 |
640121 |
640121 |
2.3 % |
14/05/2021 |
| Oncology Impact Fund (Cayman) Management LP |
|
2414787 |
0 |
2414787 |
0 |
2414787 |
8.8 % |
14/05/2021 |
| Todd Foley |
|
0 |
3214771 |
0 |
3214771 |
3214771 |
11.7 % |
14/05/2021 |
| Stephen Curtis |
|
0 |
640121 |
0 |
640121 |
640121 |
2.3 % |
14/05/2021 |
| MPM Oncology Impact Management GP LLC |
|
2414787 |
0 |
2414787 |
0 |
2414787 |
8.8 % |
14/05/2021 |
| Ansbert Gadicke |
|
0 |
6731087 |
0 |
6731087 |
6731087 |
24.4 % |
14/05/2021 |
| Luke Evnin |
|
0 |
4316300 |
0 |
4316300 |
4316300 |
15.7 % |
14/05/2021 |
| Longwood Fund III, L.P. |
Delaware |
0 |
1677082 |
0 |
1677082 |
1677082 |
6.1 % |
14/05/2021 |
| Longwood Fund III GP, LLC |
Delaware |
0 |
1677082 |
0 |
1677082 |
1677082 |
6.1 % |
14/05/2021 |
| Taiho Ventures LLC |
|
2068909 |
0 |
2068909 |
0 |
2068909 |
7.51 % |
13/05/2021 |
| RA Capital Management, L.P. |
Delaware |
0 |
3968583 |
0 |
10 |
3968583 |
14.4 % |
06/05/2021 |
| Rajeev Shah |
United States |
0 |
3968583 |
0 |
10 |
3968583 |
14.4 % |
06/05/2021 |
| Peter Kolchinsky |
United States |
0 |
3968583 |
0 |
10 |
3968583 |
14.4 % |
06/05/2021 |
| RA Capital Healthcare Fund, L.P. |
Delaware |
0 |
3524758 |
0 |
10 |
3524758 |
12.8 % |
06/05/2021 |
| James E. Flynn |
United States |
0 |
2552787 |
0 |
0 |
2552787 |
9.27 % |
04/05/2021 |
| Company, L.P. |
Delaware |
0 |
2552787 |
0 |
0 |
2552787 |
9.27 % |
04/05/2021 |
| Deerfield Mgmt, L.P. |
Delaware |
0 |
2552787 |
0 |
0 |
2552787 |
9.27 % |
04/05/2021 |
| Deerfield Partners, L.P. |
Delaware |
0 |
2552787 |
0 |
0 |
2552787 |
9.27 % |
04/05/2021 |